GlassScriptPhysician profile
Boris Zaks
NPI 1467565168
$4,784.26
in general payments reported to CMS, 2019-2025
19 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,550 · 2020: $539 · 2021: $140 · 2022: $199 · 2023: $319 · 2024: $813 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $906.65 | 2019-2025 | |
| Celgene Corporation | $788.76 | 2019 | |
| Amgen INC. | $558.19 | 2020-2024 | Otezla |
| Allergan, INC. | $500.00 | 2019 | |
| Biofrontera INC. | $472.16 | 2019 | |
| Vifor (International) LTD. | $283.33 | 2020 | |
| Prugen, INC. Pharmaceuticals | $223.63 | 2019-2021 | |
| Epi Health, LLC | $197.10 | 2019-2020 | |
| Galderma Laboratories, L.P. | $176.98 | 2020-2024 | |
| Botanix Sb INC | $154.45 | 2025 | Sofdra |
| Dermira, INC. | $124.38 | 2019 | |
| Sun Pharmaceutical Industries INC. | $121.90 | 2019 | |
| Janssen Biotech, INC. | $118.77 | 2024 | Tremfya |
| Dusa Pharmaceuticals, INC. | $43.70 | 2019 | |
| Journey Medical Corporation | $39.46 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $26.46 | 2019 | |
| Vyne Pharmaceuticals INC. | $20.27 | 2020 | |
| Pfizer INC. | $14.27 | 2022 | |
| Mission Pharmacal Company | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Zaks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.